The Discovery Of Ignorance… And Some Things About The Pathobiology Of Acute Lymphoblastic Leukemia
Tue, 30 Jun 2020

The Discovery Of Ignorance… And Some Things About The Pathobiology Of Acute Lymphoblastic Leukemia

2020 William Boyd Lecturer

At the end of the activity, participants will be able to:

List two strategies for targeting oncogenic transcription factor function therapeutically in leukemia
List two intermolecular interactions in which oncogenic transcription factors participate
Describe at least one mechanism by which somatic mutations may activate potentially oncogenic transcription factors

Target audience: Pathologists, Residents, Medical Students, Pathologists' Assistants, Laboratory Scientists.

CanMEDS Roles: Medical Expert (the integrating role), Collaborator, Scholar

Speaker: David Lebrun

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists. You may claim a maximum of 1.0 hour (credits are automatically calculated).


David Lebrun
Principal Investigator, CBG Division @Queen's University
Dr. David LeBrun obtained his M.D. from Queen's University in 1984. He completed residency in anatomical pathology at the University of Toronto in 1990 then moved to Stanford University where he underwent postdoctoral training in lymphoma diagnosis and, as a Research Fellow of the Medical Research Council Canada, in experimental research pertaining to molecular mechanisms of leukemogenesis. He has held a faculty appointment in the Department of Pathology and Molecular Medicine at Queen's University since 1994 and holds the rank of Professor. He conducts correlative and mechanistic research on lymphoma and acute lymphoblastic leukemia. His research has been supported by the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, the Leukemia & Lymphoma Society of Canada, the Cancer Research Society and the Ontario Institute for Cancer Research (OICR). Dr. LeBrun serves as the senior consultant in lymph node pathology for the Southeastern Ontario region.


- last updated September 2020 -